We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Audiocodes, Farmland Partners, Invitae, Global Medical and Glu
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Audiocodes Ltd. (AUDC - Free Report) , Farmland Partners Inc. (FPI - Free Report) , Invitae Corporation , Global Medical REIT Inc. (GMRE - Free Report) and Glu Mobile Inc. .
Here are highlights from Tuesday’s Analyst Blog:
5 of the Best tocks Under $10 for 2018
Here at Zacks, we don’t generally classify stocks as “cheap” or “expensive,” and rather than looking at the stock’s face value, we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.
That being said, low-priced stocks can be attractive to smaller investors that can’t necessarily afford large stakes in companies with higher priced shares. When looking at these low-priced stocks, we can look at the same trends in growth, value, and momentum and apply the Zacks Rank to properly analyze the potential that these companies have.
Today we’ve highlighted five stocks that are currently trading for under $10 per share. All of these stocks currently sport a Zacks Rank #2 (Buy) or better, and the selected companies are showing signs of outpacing the market in the current calendar year.
Check out these five great stocks under $10 for 2018:
1. Audiocodes Ltd.
Prior Close: $7.13
AudioCodes designs, develops and markets enabling technologies and communication components for the transmission of voice, fax and modem over packet networks. AUDC is a solid growth pick, with earnings expected to improve by 22% and revenue projected to expand by 9% this year. Meanwhile, the stock has a P/E of just 15.8, which is a discount compared to the average of our “Communication – Components” group. Its P/S ratio of 1.2 also helps show that investors are getting a great price on this stock. AUDC is currently sporting a Zacks Rank #2 (Buy).
2. Farmland Partners Inc.
Prior Close: $7.59
Farmland Partners is a real estate company which owns row crop farmland located in agricultural markets throughout North America. Farmland is slated to report its latest quarterly results tomorrow, and although earnings are expected to be flat year over year, the company is projected to witness revenue growth of nearly 64%. FPI will also be looking to extend its solid earnings streak, which now includes three consecutive estimate beats. The stock is holding a Zacks Rank #2 (Buy) ahead of its report. Income investors will also note that its status as a REIT means that it offers a juicy 6.7% dividend.
3. Invitae Corporation
Prior Close: $5.82
Invitae is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. This popular biotech growth pick is sporting a Zacks Rank #1 (Strong Buy) right now. Investors are excited about the company’s rapid revenue growth, with current estimates calling for sales to improve by 83.4% in 2018. Invitae is not yet profitable, but analysts are expecting EPS improvement of nearly 16% this year. This is also going to be hot option for M&A and partnership chatter. Just this week, Invitae expanded its relationship with Sarepta Therapeutics to help clinicians identify patients with Duchenne muscular dystrophy.
4. Global Medical REIT Inc.
Prior Close: $8.43
Global Medical is a real estimate investment company engaged in the acquisition of purpose-built healthcare facilities and the leasing of these facilities to clinical operators. GMRE presents a dividend yield of about 9.5%, and the stock currently holds a Zacks Rank #2 (Buy). This is also an aggressive growth pick for 2018. According to our latest Zacks Consensus Estimates, analysts are expecting GMRE to witness EPS growth of 39% and revenue growth of 75% in the current fiscal year. However, the stock has a PEG ratio of just 1.3, so investors are getting a discount on this growth potential.
5. Glu Mobile Inc.
Prior Close: $5.25
Glu Mobile is a leading global publisher of mobile games, including top-rated original titles and titles based on major brands from partners like Activision and Hasbro. Glu is bouncing into a profitable year, with earnings expected to improve by 150% to touch $0.22 per share in 2018. Meanwhile, revenue is projected to grow by 18%. The stock now has a Zacks Rank #2 (Buy). This is also a popular momentum option right now after shares skyrocketed about 43% in the past month. Investors looking to follow this trend should appreciate that analyst sentiment has improved strongly as well.
Bottom Line
A stock’s market price is certainly not the most important factor to consider when considering whether or not to add it to your portfolio, and sales and earnings growth projections can prove to be tough to live up to.
Nevertheless, we can always use Zacks’ proven methods of finding quality stocks, and these five companies just happen to be showing strength while also trading for under $10 per share.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Audiocodes, Farmland Partners, Invitae, Global Medical and Glu
For Immediate Release
Chicago, IL – May 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Audiocodes Ltd. (AUDC - Free Report) , Farmland Partners Inc. (FPI - Free Report) , Invitae Corporation , Global Medical REIT Inc. (GMRE - Free Report) and Glu Mobile Inc. .
Here are highlights from Tuesday’s Analyst Blog:
5 of the Best tocks Under $10 for 2018
Here at Zacks, we don’t generally classify stocks as “cheap” or “expensive,” and rather than looking at the stock’s face value, we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.
That being said, low-priced stocks can be attractive to smaller investors that can’t necessarily afford large stakes in companies with higher priced shares. When looking at these low-priced stocks, we can look at the same trends in growth, value, and momentum and apply the Zacks Rank to properly analyze the potential that these companies have.
Today we’ve highlighted five stocks that are currently trading for under $10 per share. All of these stocks currently sport a Zacks Rank #2 (Buy) or better, and the selected companies are showing signs of outpacing the market in the current calendar year.
Check out these five great stocks under $10 for 2018:
1. Audiocodes Ltd.
Prior Close: $7.13
AudioCodes designs, develops and markets enabling technologies and communication components for the transmission of voice, fax and modem over packet networks. AUDC is a solid growth pick, with earnings expected to improve by 22% and revenue projected to expand by 9% this year. Meanwhile, the stock has a P/E of just 15.8, which is a discount compared to the average of our “Communication – Components” group. Its P/S ratio of 1.2 also helps show that investors are getting a great price on this stock. AUDC is currently sporting a Zacks Rank #2 (Buy).
2. Farmland Partners Inc.
Prior Close: $7.59
Farmland Partners is a real estate company which owns row crop farmland located in agricultural markets throughout North America. Farmland is slated to report its latest quarterly results tomorrow, and although earnings are expected to be flat year over year, the company is projected to witness revenue growth of nearly 64%. FPI will also be looking to extend its solid earnings streak, which now includes three consecutive estimate beats. The stock is holding a Zacks Rank #2 (Buy) ahead of its report. Income investors will also note that its status as a REIT means that it offers a juicy 6.7% dividend.
3. Invitae Corporation
Prior Close: $5.82
Invitae is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. This popular biotech growth pick is sporting a Zacks Rank #1 (Strong Buy) right now. Investors are excited about the company’s rapid revenue growth, with current estimates calling for sales to improve by 83.4% in 2018. Invitae is not yet profitable, but analysts are expecting EPS improvement of nearly 16% this year. This is also going to be hot option for M&A and partnership chatter. Just this week, Invitae expanded its relationship with Sarepta Therapeutics to help clinicians identify patients with Duchenne muscular dystrophy.
4. Global Medical REIT Inc.
Prior Close: $8.43
Global Medical is a real estimate investment company engaged in the acquisition of purpose-built healthcare facilities and the leasing of these facilities to clinical operators. GMRE presents a dividend yield of about 9.5%, and the stock currently holds a Zacks Rank #2 (Buy). This is also an aggressive growth pick for 2018. According to our latest Zacks Consensus Estimates, analysts are expecting GMRE to witness EPS growth of 39% and revenue growth of 75% in the current fiscal year. However, the stock has a PEG ratio of just 1.3, so investors are getting a discount on this growth potential.
5. Glu Mobile Inc.
Prior Close: $5.25
Glu Mobile is a leading global publisher of mobile games, including top-rated original titles and titles based on major brands from partners like Activision and Hasbro. Glu is bouncing into a profitable year, with earnings expected to improve by 150% to touch $0.22 per share in 2018. Meanwhile, revenue is projected to grow by 18%. The stock now has a Zacks Rank #2 (Buy). This is also a popular momentum option right now after shares skyrocketed about 43% in the past month. Investors looking to follow this trend should appreciate that analyst sentiment has improved strongly as well.
Bottom Line
A stock’s market price is certainly not the most important factor to consider when considering whether or not to add it to your portfolio, and sales and earnings growth projections can prove to be tough to live up to.
Nevertheless, we can always use Zacks’ proven methods of finding quality stocks, and these five companies just happen to be showing strength while also trading for under $10 per share.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.